Clinical Trial Update: A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED) [Phase 3]

View source ↗

Summary

A Phase 3 weight-maintenance trial in obese patients sponsored by Merck Sharp & Dohme was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 3 | Status: TERMINATED